| Effects of dalcetrapib in patients with a recent acute coronary syndrome GG Schwartz, AG Olsson, M Abt, CM Ballantyne, PJ Barter, J Brumm, ... New England Journal of Medicine 367 (22), 2089-2099, 2012 | 2334 | 2012 |
| Mechanism of action of fibrates on lipid and lipoprotein metabolism B Staels, J Dallongeville, J Auwerx, K Schoonjans, E Leitersdorf, ... Circulation 98 (19), 2088-2093, 1998 | 2146 | 1998 |
| Atherosclerosis in the apolipoprotein E–deficient mouse: a decade of progress KS Meir, E Leitersdorf Arteriosclerosis, thrombosis, and vascular biology 24 (6), 1006-1014, 2004 | 710 | 2004 |
| Risk for myopathy with statin therapy in high-risk patients CM Ballantyne, A Corsini, MH Davidson, H Holdaas, TA Jacobson, ... Archives of internal medicine 163 (5), 553-564, 2003 | 599 | 2003 |
| Common low-density lipoprotein receptor mutations in the French Canadian population. E Leitersdorf, EJ Tobin, J Davignon, HH Hobbs The Journal of clinical investigation 85 (4), 1014-1023, 1990 | 356 | 1990 |
| Markedly reduced bile acid synthesis but maintained levels of cholesterol and vitamin D metabolites in mice with disrupted sterol 27-hydroxylase gene H Rosen, A Reshef, N Maeda, A Lippoldt, S Shpizen, L Triger, ... Journal of Biological Chemistry 273 (24), 14805-14812, 1998 | 291 | 1998 |
| Elimination of cholesterol in macrophages and endothelial cells by the sterol 27-hydroxylase mechanism: comparison with high density lipoprotein-mediated reverse cholesterol … A Babiker, O Andersson, E Lund, RJ Xiu, S Deeb, A Reshef, E Leitersdorf, ... Journal of Biological Chemistry 272 (42), 26253-26261, 1997 | 289 | 1997 |
| Consensus for the use of fibrates in the treatment of dyslipoproteinemia and coronary heart disease. Fibrate Consensus Group. JC Fruchart, HB Brewer Jr, E Leitersdorf The American journal of cardiology 81 (7), 912-917, 1998 | 285 | 1998 |
| Possible association between diabetes and bisphosphonate-related jaw osteonecrosis M Khamaisi, E Regev, N Yarom, B Avni, E Leitersdorf, I Raz, S Elad The Journal of Clinical Endocrinology & Metabolism 92 (3), 1172-1175, 2007 | 261 | 2007 |
| Effects of initiating moderate alcohol intake on cardiometabolic risk in adults with type 2 diabetes: a 2-year randomized, controlled trial Y Gepner, R Golan, I Harman-Boehm, Y Henkin, D Schwarzfuchs, I Shelef, ... Annals of internal medicine 163 (8), 569-579, 2015 | 241 | 2015 |
| Refinement of variant selection for the LDL cholesterol genetic risk score in the diagnosis of the polygenic form of clinical familial hypercholesterolemia and replication in … M Futema, S Shah, JA Cooper, KW Li, RA Whittall, M Sharifi, O Goldberg, ... Clinical chemistry 61 (1), 231-238, 2015 | 240 | 2015 |
| Identification of bile acid precursors as endogenous ligands for the nuclear xenobiotic pregnane X receptor B Goodwin, KC Gauthier, M Umetani, MA Watson, MI Lochansky, ... Proceedings of the National Academy of Sciences 100 (1), 223-228, 2003 | 231 | 2003 |
| Disruption of the sterol 27-hydroxylase gene in mice results in hepatomegaly and hypertriglyceridemia: reversal by cholic acid feeding JJ Repa, EG Lund, JD Horton, E Leitersdorf, DW Russell, JM Dietschy, ... Journal of Biological Chemistry 275 (50), 39685-39692, 2000 | 226 | 2000 |
| Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) AJ Vallejo-Vaz, CAT Stevens, ARM Lyons, KI Dharmayat, T Freiberger, ... The Lancet 398 (10312), 1713-1725, 2021 | 223 | 2021 |
| Two common low density lipoprotein receptor gene mutations cause familial hypercholesterolemia in Afrikaners. E Leitersdorf, DR Van der Westhuyzen, GA Coetzee, HH Hobbs The Journal of clinical investigation 84 (3), 954-961, 1989 | 222 | 1989 |
| Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome GG Schwartz, AG Olsson, CM Ballantyne, PJ Barter, IM Holme, D Kallend, ... American heart journal 158 (6), 896-901. e3, 2009 | 213 | 2009 |
| Frameshift and splice-junction mutations in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis in Jews or Moroccan origin. E Leitersdorf, A Reshef, V Meiner, R Levitzki, SP Schwartz, EJ Dann, ... The Journal of clinical investigation 91 (6), 2488-2496, 1993 | 212 | 1993 |
| Platelet factor 4 enhances the binding of oxidized low-density lipoprotein to vascular wall cells T Nassar, BS Sachais, S Akkawi, MA Kowalska, K Bdeir, E Leitersdorf, ... Journal of Biological Chemistry 278 (8), 6187-6193, 2003 | 197 | 2003 |
| A truncated human peroxisome proliferator-activated receptor α splice variant with dominant negative activity P Gervois, IP Torra, G Chinetti, T Grotzinger, G Dubois, JC Fruchart, ... Molecular Endocrinology 13 (9), 1535-1549, 1999 | 196 | 1999 |
| Evidence for a dominant gene that suppresses hypercholesterolemia in a family with defective low density lipoprotein receptors. HH Hobbs, E Leitersdorf, CC Leffert, DR Cryer, MS Brown, JL Goldstein The Journal of clinical investigation 84 (2), 656-664, 1989 | 170 | 1989 |
John McMurrayUniversity of Glasgow.כתובת אימייל מאומתת בדומיין glasgow.ac.uk
